|
ATN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.497400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.915600E-01 |
| Normal-vs-Stage2 |
2.337800E-01 |
| Normal-vs-Stage3 |
4.214400E-01 |
| Normal-vs-Stage4 |
3.082000E-01 |
| Stage1-vs-Stage2 |
1.495190E-01 |
| Stage1-vs-Stage3 |
3.295400E-01 |
| Stage1-vs-Stage4 |
1.982210E-01 |
| Stage2-vs-Stage3 |
6.665600E-01 |
| Stage2-vs-Stage4 |
7.771000E-01 |
| Stage3-vs-Stage4 |
8.357000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.450400E-01 |
| Normal-vs-AfricanAmerican |
7.671200E-01 |
| Normal-vs-Asian |
2.502400E-01 |
| Caucasian-vs-AfricanAmerican |
3.031200E-01 |
| Caucasian-vs-Asian |
1.926640E-01 |
| AfricanAmerican-vs-Asian |
4.256800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.147400E-01 |
| Normal-vs-Female |
5.131600E-01 |
| Male-vs-Female |
6.675100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.609800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.367000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.646800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.279580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.970400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.445400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.277400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.426100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.297200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.644000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.032910E-04 |
| Normal-vs-Grade 2 |
9.577200E-01 |
| Normal-vs-Grade 3 |
1.321240E-01 |
| Normal-vs-Grade 4 |
3.548400E-01 |
| Grade 1-vs-Grade 2 |
2.159300E-04 |
| Grade 1-vs-Grade 3 |
1.82564999999801E-05 |
| Grade 1-vs-Grade 4 |
8.39040000000235E-05 |
| Grade 2-vs-Grade 3 |
2.818000E-02 |
| Grade 2-vs-Grade 4 |
2.457800E-01 |
| Grade 3-vs-Grade 4 |
6.662200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.663200E-01 |
| Normal-vs-ccB subtype |
2.948000E-01 |
| ccA subtype-vs-ccB subtype |
1.273010E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.393800E-01 |
| Normal-vs-N1 |
9.093000E-01 |
| N0-vs-N1 |
7.088400E-01 |
|
|
